 |
|
|
|
 |
| Osteoporosis can strike people of any age and ethnicity and is a major public health threat for an estimated 44 million Americans, 68 percent of them women.
In the U.S. today, 10 million individuals are estimated to already have the disease and almost 34 million more are thought to have low bone mass, placing them at
increased risk for this disease. Fast, convenient and simple to perform, our Osteomark NTx ELISAs provide an accurate measurement of bone resorption aiding
in the diagnosis and monitoring of osteoporosis patients and in predicting accelerated decrease in bone mass in postmenopausal women. When used in conjunction with
bone mineral density (BMD), Osteomark NTx gives a more complete picture of bone status than either technology alone. Both urine and serum test kits are available. |
|
|
|
| Useful Downloads |
|
|
 |
|
